Abraham N. Ceesay owns 1.16% of Rapport Therapeutics
554,703 shares as of the October 7, 2026 filing, worth $15.3M at the latest close.
RAPP · $1.3B market capGet an email when Abraham N. Ceesay’s stake moves.
Free.
The stake
1.16%
worth $15.3M at the latest close
Stake rank
#1,413
by dollar value of the stake
Last sale
12 days ago
Oct 7, 2026
Last buy
None
no purchases since 2025
Abraham N. Ceesay owns 1.16% of Rapport Therapeutics, Inc.: 554,703 of 47,978,286 shares, worth about $15.3M at the 2026-10-16 close. The stake has moved from 2.16% in 2024 to 1.16% on 2026-10-07, across 14 sales and 0 purchases that moved it since 2016. The last trade that moved it was a planned sale of $143,273 on 2026-10-07.
How the stake is held
as of the Oct 7, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Oct 7, 2026 · Form 4 ↗
HELD DIRECTLY
452,245
81.5%
HELD INDIRECTLY · 2 VEHICLES
102,458
18.5%
By Ceesay Family Irrevocable Trust
81,729
14.7%
By Dorothy Ceesay Irrevocable Trust
20,729
3.7%
THE STAKE
554,703
1.16%